XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect of Accounting Change [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Cumulative Effect of Accounting Change [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect of Accounting Change [Member]
Balance at Dec. 31, 2019 $ 818,187   $ 8 $ 3,112,130   $ 50 $ (2,294,001)  
Balance (in shares) at Dec. 31, 2019     75,185,000          
Exercise of options for common stock 3,687     3,687        
Exercise of options for common stock, shares     97,000          
Vest of restricted stock units     98,000          
Issuance of common stock to Roche, net of issuance costs 312,053     312,053        
Issuance of common stock to Roche, net of issuance costs, shares     2,522,000          
Issuance of common stock under employee stock purchase plan 3,795     3,795        
Issuance of common stock under employee stock purchase plan, shares     56,000          
Stock-based compensation 24,024     24,024        
Unrealized gains (losses) from available-for-sale securities, net of tax 574         574    
Net loss (17,492)           17,492  
Balance at Mar. 31, 2020 1,144,828   $ 8 3,455,689   624 (2,311,493)  
Balance (in shares) at Mar. 31, 2020     77,958,000          
Balance at Dec. 31, 2019 818,187   $ 8 3,112,130   50 (2,294,001)  
Balance (in shares) at Dec. 31, 2019     75,185,000          
Net loss (364,811)              
Balance at Sep. 30, 2020 892,047   $ 8 3,550,857   (6) (2,658,812)  
Balance (in shares) at Sep. 30, 2020     78,790,000          
Balance at Mar. 31, 2020 1,144,828   $ 8 3,455,689   624 (2,311,493)  
Balance (in shares) at Mar. 31, 2020     77,958,000          
Exercise of options for common stock 21,860     21,860        
Exercise of options for common stock, shares     449,000          
Vest of restricted stock units     25,000          
Stock-based compensation 27,616     27,616        
Unrealized gains (losses) from available-for-sale securities, net of tax (618)         618    
Net loss (150,820)           150,820  
Balance at Jun. 30, 2020 1,042,866   $ 8 3,505,165   6 (2,462,313)  
Balance (in shares) at Jun. 30, 2020     78,432,000          
Exercise of options for common stock, shares     292,000          
Vest of restricted stock units     20,000          
Issuance of common stock under employee stock purchase plan 3,670     3,670        
Issuance of common stock under employee stock purchase plan, shares     46,000          
Stock-based compensation 26,903     26,903        
Unrealized gains (losses) from available-for-sale securities, net of tax (12)         12    
Net loss (196,499)           196,499  
Balance at Sep. 30, 2020 892,047   $ 8 3,550,857   (6) (2,658,812)  
Balance (in shares) at Sep. 30, 2020     78,790,000          
Balance at Dec. 31, 2020 761,759 $ (96,792) $ 8 3,609,877 $ (156,953) 3 (2,848,129) $ 60,161
Balance (in shares) at Dec. 31, 2020     79,374,000          
Exercise of options for common stock 4,683     4,683        
Exercise of options for common stock, shares     108,000          
Vest of restricted stock units     204,000          
Issuance of common stock under employee stock purchase plan 4,543     4,543        
Issuance of common stock under employee stock purchase plan, shares     62,000          
Stock-based compensation 28,508     28,508        
Unrealized gains (losses) from available-for-sale securities, net of tax (6)         (6)    
Net loss (167,250)           (167,250)  
Balance at Mar. 31, 2021 535,445   $ 8 3,490,658   (3) (2,955,218)  
Balance (in shares) at Mar. 31, 2021     79,748,000          
Balance at Dec. 31, 2020 761,759 $ (96,792) $ 8 3,609,877 $ (156,953) 3 (2,848,129) $ 60,161
Balance (in shares) at Dec. 31, 2020     79,374,000          
Net loss (296,799)              
Balance at Sep. 30, 2021 469,528   $ 8 3,554,307   (20) (3,084,767)  
Balance (in shares) at Sep. 30, 2021     79,959          
Balance at Mar. 31, 2021 535,445   $ 8 3,490,658   (3) (2,955,218)  
Balance (in shares) at Mar. 31, 2021     79,748,000          
Exercise of options for common stock 3,526     3,526        
Exercise of options for common stock, shares     72,000          
Vest of restricted stock units     28,000          
Shares withheld for taxes (1,432)     (1,432)        
Shares withheld for taxes, shares     (18,000)          
Stock-based compensation 28,969     28,969        
Unrealized gains (losses) from available-for-sale securities, net of tax 5         5    
Net loss (81,405)           (81,405)  
Balance at Jun. 30, 2021 485,108   $ 8 3,521,721   2 (3,036,623)  
Balance (in shares) at Jun. 30, 2021     79,830,000          
Exercise of options for common stock 2,606     2,606        
Exercise of options for common stock, shares     52,000          
Vest of restricted stock units     27,000          
Issuance of common stock under employee stock purchase plan 3,296     3,296        
Issuance of common stock under employee stock purchase plan, shares     50,000          
Stock-based compensation 26,684     26,684        
Unrealized gains (losses) from available-for-sale securities, net of tax (22)         (22)    
Net loss (48,144)           (48,144)  
Balance at Sep. 30, 2021 $ 469,528   $ 8 $ 3,554,307   $ (20) $ (3,084,767)  
Balance (in shares) at Sep. 30, 2021     79,959